Education
| School ¡X Major ¡X Degree | Duration |
|---|---|
|
°ê¥ß°ê¨¾Âå¾Ç°| ¡X ¥Í©R¬ì¾Ç¬ã¨s©Ò(²¦) ¡X ³Õ¤h Doctorate, , |
2000/09 ¡X 2004/04 |
|
«X¥è«X¦{¥ß¤j¾Ç ¡X ¤À¤l¿ò¶Ç©Ò(²¦) ¡X ºÓ¤h Master, , |
1995/09 ¡X 1998/08 |
|
°ê¥ß»OÆW¤j¾Ç ¡X °Êª«¾Ç¬ã¨s©Ò(²¦) ¡X ºÓ¤h Master, , |
1991/09 ¡X 1993/06 |
|
°ê¥ß»OÆW¤j¾Ç ¡X °Êª«¾Ç¨t(²¦) ¡X ¾Ç¤h Bachelor, , |
1987/09 ¡X 1991/06 |
Intramural Experience
| Office/Department/Institute | Position | Duration |
|---|---|---|
| ¥Íª«¬ì§Þ¾Ç¨t Department of Biotechnology | Professor | 2015/02/01 ¡X |
| ¥Íª«¬ì§Þ¾Ç¨t Department of Biotechnology | Associate Professor | 2010/08/01 ¡X 2015/01/31 |
| ¥Íª«¬ì§Þ¾Ç¨t Department of Biotechnology | Assistant Professor | 2004/08/16 ¡X 2010/07/31 |
Extramural Experience
Discipline
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
¤Æ¾Ç¦X¦¨¡B¤ÑµMÃĪ«¡BÁ{§ÉÂå¾Ç
Area(s) of Expertise & Research
Àù¯g¤ÆÀø§ÜÃľ÷Âà, Âb·}¤À¤l²ÓM¥Íª«¾Ç,¥Íª«§Þ³N¹êÅç,¸~½F°ò¦]Åé¾Ç
Publication
| NO | Publication |
|---|---|
| 1 | Areca nut-induced metabolic reprogramming and M2 differentiation promote OPMD malignant transformation. Areca nut-induced metabolic reprogramming and M2 differentiation promote OPMD malignant transformation. |
| 2 | ¦ÑÃÄ·s¥Î§Üºë¯«¯fÃĪ«¤T¬t©Ô嗪³z¹L ROS/¦Û¾½³~®|»¤¾É SLC7A11/GPX4 ½Õ±±ªº¤fµÄÀùÅK¦º¤` Repurposing of the Antipsychotic Trifluoperazine Induces SLC7A11/GPX4- Mediated Ferroptosis of Oral Cancer via the ROS/Autophagy Pathway |
| 3 | Resistance to the platinum‑based chemotherapeutic drugs in oral cancer: Focus on the role of p22phox (Review). Resistance to the platinum‑based chemotherapeutic drugs in oral cancer: Focus on the role of p22phox (Review). |
| 4 | ¥Õªá¤¦¯ÀÂÇ¥ÑROS½Õ±±ªº¤º½èºôÀ£¤O©M²É½uÅé¥\¯à»Ùê³y¦¨§ÜÃĩʤfµÄÀù细Mä¤` Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction |
| 5 | ¶ê¨rªºÁ{§É©M¿ò¶Ç¡G«eªuºîz Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review. |
| 6 | Female Pattern Hair Loss: An Overview with Focus on the Genetics. Female Pattern Hair Loss: An Overview with Focus on the Genetics. |
| 7 | Endoglin Modulates TGF£]R2 Induced VEGF and Proinflammatory Cytokine Axis Mediated Angiogenesis in Prolonged DEHP-Exposed Breast Cancer Cells Endoglin Modulates TGF£]R2 Induced VEGF and Proinflammatory Cytokine Axis Mediated Angiogenesis in Prolonged DEHP-Exposed Breast Cancer Cells |
| 8 | diTFPP, a Phenoxyphenol, Sensitizes Hepatocellular Carcinoma Cells to C-Ceramide-Induced Autophagic Stress by Increasing Oxidative Stress and ER Stress Accompanied by LAMP2 Hypoglycosylation. diTFPP, a Phenoxyphenol, Sensitizes Hepatocellular Carcinoma Cells to C-Ceramide-Induced Autophagic Stress by Increasing Oxidative Stress and ER Stress Accompanied by LAMP2 Hypoglycosylation. |
| 9 | Second-to-fourth digit ratio and age predicting the severity of androgenetic alopecia: a cross-sectional study Second-to-fourth digit ratio and age predicting the severity of androgenetic alopecia: a cross-sectional study |
| 10 | The Role of Nonapoptotic Programmed Cell Death - Ferroptosis, Necroptosis, and Pyroptosis - in Pancreatic Ductal Adenocarcinoma Treatment. The Role of Nonapoptotic Programmed Cell Death - Ferroptosis, Necroptosis, and Pyroptosis - in Pancreatic Ductal Adenocarcinoma Treatment. |
| 11 | ºñ½t»Ä§í¨î¹¹DÅ쪬²ÓMÀùÂಾ¬O¸g¥ÑEGFR/p-Akt/Snail³~®| Chlorogenic acid inhibition Esophageal Squamous Cell Carcinoma metastasis by EGFR/p-Akt/Snail signaling pathways |
| 12 | The Phenoxyphenol Compound diTFPP Mediates Exogenous C2-Ceramide Metabolism, Inducing Cell Apoptosis Accompanied by ROS Formation and Autophagy in Hepatocellular Carcinoma Cells. The Phenoxyphenol Compound diTFPP Mediates Exogenous C2-Ceramide Metabolism, Inducing Cell Apoptosis Accompanied by ROS Formation and Autophagy in Hepatocellular Carcinoma Cells. |
| 13 | »óµÄÄé¬~²G¥~ªcÅ餤Öß³J¥Õ 5AC ÅãµÛ¤W½Õ¡A¥i¯à«P¶i COX-2¡BVEGF ©M MMP-9 ªºªí¹F¡G¹ï»ó®§¦×µo¯f¾÷¨îªº¼vÅT Mucin 5AC is significantly upregulated in exosomes from the nasal lavage fluid and may promote the expression of COX-2, VEGF and MMP-9: an implication in nasal polyp pathogenesis |
| 14 | Curcumin Metabolite Tetrahydrocurcumin in the Treatment of Eye Diseases. Curcumin Metabolite Tetrahydrocurcumin in the Treatment of Eye Diseases. |
| 15 | Autophagy Is Deficient and May be Negatively Regulated by SERPINB3 in,Middle Ear Cholesteatoma Autophagy Is Deficient and May be Negatively Regulated by SERPINB3 in,Middle Ear Cholesteatoma |
| 16 | ²ÓM¦Û¾½¦b¤¤¦ÕÁx¯×½F¤¤¯Ê¥F¨Ã¥i¯à³QSERPINB3t±½Õ±± Autophagy Is Deficient and May be Negatively Regulated by SERPINB3 in Middle Ear Cholesteatoma |
| 17 | ¤º½èºô½¤³J¥Õp22phox³z¹L»P¶¶¹`ª½±µµ²¦X³y¦¨¤fµÄÀù¶¶¹`§ÜÃÄ©Ê Direct Binding of Cisplatin to p22phox, an Endoplasmic Reticulum (ER) Membrane Protein, Contributes to Cisplatin Resistance in Oral Squamous Cell Carcinoma (OSCC) Cells |
| 18 | Human non‑small cell lung cancer cells can be sensitized to camptothecin by modulating autophagy Human non‑small cell lung cancer cells can be sensitized to camptothecin by modulating autophagy |
| 19 | A Quinone-Containing Compound Enhances Camptothecin-Induced Apoptosis of Lung Cancer Through Modulating Endogenous ROS and ERK Signaling. A Quinone-Containing Compound Enhances Camptothecin-Induced Apoptosis of Lung Cancer Through Modulating Endogenous ROS and ERK Signaling. |
| 20 | An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation |
| 21 | An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation |
| 22 | An Iron-Catalyzed Cascade Approach to Benzo[b]carbazole Synthesis Followed by 1,4-Sulfonyl Migration An Iron-Catalyzed Cascade Approach to Benzo[b]carbazole Synthesis Followed by 1,4-Sulfonyl Migration |
| 23 | Vitamin D decreases the secretion of eotaxin and RANTES in nasal polyp fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyps Vitamin D decreases the secretion of eotaxin and RANTES in nasal polyp fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyps |
| 24 | Vitamin D decreases the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyposis. Vitamin D decreases the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyposis. |
| 25 | Autophagy is deficient in nasal polyps: implications for the pathogenesis of the disease. Autophagy is deficient in nasal polyps: implications for the pathogenesis of the disease. |
| 26 | BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9 BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9 |
| 27 | ºØ¨t°ÊºA««Ø¬_ÂÄ©_ B2¯f¬r¤§®ÉªÅ´²§G©M±Ú¸sÅܤƾúµ{ Phylodynamic reconstruction of the spatiotemporal transmission and demographic history of coxsackievirus B2 |
| 28 | Autophagy is deficient and inversely correlated with COX-2 expression in nasal polyps: a novel insight into the inflammation mechanism. Autophagy is deficient and inversely correlated with COX-2 expression in nasal polyps: a novel insight into the inflammation mechanism. |
| 29 | Serine protease inhibitor-1 (SERPIN) B1 promotes oral cancer cell mobility and is over-expressed in invasive squamous cell carcinoma Serine protease inhibitor-1 (SERPIN) B1 promotes oral cancer cell mobility and is over-expressed in invasive squamous cell carcinoma |
| 30 | 13-Acetoxysarcocrassolide induces apoptosis on human gastric carcinoma cells through mitochondria-related apoptotic pathways: p38/JNK activation and PI3K/AKT suppression 13-Acetoxysarcocrassolide induces apoptosis on human gastric carcinoma cells through mitochondria-related apoptotic pathways: p38/JNK activation and PI3K/AKT suppression |
| 31 | CYP26B1ªº®t²§ªí²{»PÂb·}¤Þ°_¤fµÄÀùªºÃö«Y Expression of a Splice Variant of CYP26B1 in Betel Quid-Related Oral Cancer |
| 32 | Calreticulin,¤@Ó¤º½èºô³J¥Õ,°ª«×ªí²{¨Ã¹ï©ó¤fµÄÀù²ÓM¥Íªø»P²¾Âà§êºt«n¨¤¦â Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. |
| 33 | Serum 25-hydroxyvitamin D levels are lower in chronic rhinosinusitis with nasal polyposis and are correlated with disease severity in Taiwanese patients. Serum 25-hydroxyvitamin D levels are lower in chronic rhinosinusitis with nasal polyposis and are correlated with disease severity in Taiwanese patients. |
| 34 | Âb·}¤lµÑ¨ú²G³z¹L¼W¥[¬¡©Ê®ñ¤À¤l»P§í¨îGSK3£]»¤µo¦å²M°§¾j¤fµÄÀù²ÓM©TÁYÃa¦º Areca nut extract induces pyknotic necrosis in serum-starved oral cells via increasing reactive oxygen species and inhibiting GSK3£]: an implication for cytopathic effects in betel quid chewers |
| 35 | Anti-allergic activity of grape seed extract (GSE) on RBL-2H3 mast cells Anti-allergic activity of grape seed extract (GSE) on RBL-2H3 mast cells |
| 36 | ©@°Ø»Ä¹ï©ó¤Ó¥¬vµµ§ü¾J§í¨î¥Íªø¯à³z¹LNF-£eB¸ô®|¹ïªÍÀù²ÓM´£¨Ñ«OÅ@§@¥Î Protective Effect of Caffeic Acid on Paclitaxel Induced Anti-Proliferation and Apoptosis of Lung Cancer Cells Involves NF-£eB Pathway |
| 37 | ²ÓM¦Û¾½»P¬¡©Ê®ñ¤Æª«¯à½Õ¸`¦]§í¨îATM¿E酶©Ò¤Þ°_¤§ÀYÀVÀù²ÓMªº¦º¤` Autophagy and reactive oxygen species modulate cytotoxicity induced by suppression of ATM kinase activity in head and neck cancer cells |
| 38 | Âb·}ÆP³z¹L¬¡©Ê®ñ/mTOR complex 1³~®|¤U½Õ±±p21¤Îp27¨Ã¥i¯à³y¦¨¤fµÄ¤W¥ÖÅ쪬²ÓMÀù Arecoline downregulates levels of p21 and p27 through the reactive oxygen species/mTOR complex1 pathway and may contribute to oral squamous cell carcinoma |
| 39 | Reversine ³z¹L²ÓM¶g´Á°±º¢»P¦ñÀHµo¥Í¤§²ÓMä¤`¤Î¦Û¾½§í¨î¤fµÄÅ쪬²ÓMÀù Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy |
| 40 | 11-Dehydrosinulariolide ³z¹L²É½uÅ饢½Õ»P¤º½èºôÀ£¤O»¤µo¤HÃþ¶Â¦â¯À²ÓMÀùä¤` Induction of apoptosis by 11-Dehydrosinulariolide via mitochondrial dysregulation and ER stress pathways in human melanoma cells |
| 41 | §Q¥Î³J¥ÕÅé±´°Qsinularin¹ï¶Â¦â¯À²ÓM½FA2058ªº§ÜÀù¬¡©Ê Proteomic investigation of anti-tumor activities exerted by sinularin against A2058 melanoma cells |
| 42 | µµÀ@µâµÑ¨úª«»¤¾É¤j¸zÀù²ÓM¤§ä¤` Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis |
| 43 | RhoGDP ¤ÀÂ÷§í¨î¦]¤l¹L«×ªí²{¥i¥H¹w´ú¤fµÄ¤W¥ÖÅ쪬²ÓMÀùªº§C¦s¬¡²v Overexpression of Rho GDP-dissociation inhibitor alpha predicts poor survival in oral squamous cell carcinoma |
| 44 | §Q¥Î³J¥ÕÅé¤ÀªR11-Dehydrosinulariolide ¦bCAL-27²ÓMªº§ÜÀù®ÄªG Proteomic Analysis of Anti-Tumor Effects of 11-Dehydrosinulariolide on CAL-27 Cells |
| 45 | §Q¥Î®z³±Â÷¤l¥æ´«¼hªRªk¯Â¤Æ§¿²G³J¥ÕÅ馳§UŲ©w¥X§C¶q³J¥Õ Identification of low-abundance proteins via fractionation of the urine proteome with weak anion exchange chromatography |
| 46 | 4£]-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G2/M arrest 4£]-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G2/M arrest |
| 47 | ÆFªÛµÑ¨úª«¨ó¦P¼W±j§ÜÀùÃĪ«¬r±þ¨ã§ÜÃĩʤ§ªc§¿¤W¥ÖÀù²ÓM Ling-Zhi Polysaccharides Potentiates Cytotoxic Effects of Anticancer Drugs Against Drug-Resistant Urothelial Carcinoma Cells |
| 48 | Additive effects of C2-ceramide on Paclitaxel-induced premature senescence of human lung cancer cells Additive effects of C2-ceramide on Paclitaxel-induced premature senescence of human lung cancer cells |
| 49 | Betel quid extract promotes oral cancer cell migration by activating a muscarinic M4 receptor-mediated signaling cascade involving SFKs and ERK1/2 Betel quid extract promotes oral cancer cell migration by activating a muscarinic M4 receptor-mediated signaling cascade involving SFKs and ERK1/2 |
| 50 | Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan |
| 51 | p38 MAPK and NF-£eB pathways are involved in naphtho[1,2-b]furan-4,5-dione induced anti-proliferation and apoptosisof human hepatoma cells p38 MAPK and NF-£eB pathways are involved in naphtho[1,2-b]furan-4,5-dione induced anti-proliferation and apoptosisof human hepatoma cells |
| 52 | ¹¹DÀù²ÓM®è«I¥Ç¦¸±Ú¸s¤À¤l¥\¯à¤ÀªR Molecular characterization of invasive subpopulations fro esophageal squamous cell carcinomam an cell line. |
| 53 | ¿¹ÃþµÑ¨ú¤Æ¦Xª« protoapigenone »¤¾ÉªÍÀù²ÓMH1299ªºDNA·lÃa¤Î²ÓM¶g´ÁG2/M´Á°±º¢ Fern plant-derived protoapigenone leads to DNA damage, apoptosis and G2/M arrest in lung cancer cell line H1299 |
| 54 | SERPINB1 «P¶i¤fµÄÀù²ÓM²¾Âà¨Ã¹L«×ªí²{©ó«I¥Ç©Ê¤fµÄÅ쪬²ÓMÀù Serine Protease Inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma |
| 55 | MAP2 °Ñ»P¤fµÄÀù²ÓM²¾Âà: ¤@ÓMAP2¦b«D¯«¸g²ÓMªº·s¿o¥\¯à Involvement of microtubule-associated protein 2 (MAP2) in oral cancer cell motility: A novel biological function of MAP2 in non-neuronal cells |
| 56 | Src®a±Ú¿E×Q´C¤¶Âb·}²G»¤µo¤§¤fµÄÀù²ÓM²¾Âà¥B¥i¯à¦¨¬°¤fµÄÀù¦´Á«I¥Ç§@¥Î¤§¥Íª«¼Ð°O Src Family Kinases Mediate Betel Quid¡VInduced Oral Cancer Cell Motility and Could Be a Biomarker for Early Invasion in Oral Squamous Cell Carcinoma |
Project
| NO |
YEAR ¡X Source ¡X No ¡X Type
Project Name
|
Duration |
|---|---|---|
| 1 |
112 ¡X M °ªÂå(ºØ¤lpµe) ¡X KMU-M113017 ¡X
«Ø¥ß¥H»Ã¥ÀµßÂùÂø¥æ¨t²Î¬°°ò¦ªº·s«aªÍª¢ÃĪ«¿z¿ï¥¥x:¥H·s«¬«aª¬¯f¬r(SARS-CoV-2)®Ö´ß³J¥Õ¦Û§Úµ²¦X¬°ÃĪ«¼Ð¹v¤Î½d¨Ò( )
|
2024/01/01 ~ 2024/12/31 |
| 2 |
111 ¡X M °ªÂå(ºØ¤lpµe) ¡X KMU-M12010 ¡X
¤º½èºô³J¥Õp22phox³z¹LÂàͼh±½Õ±±»¤¾É¤fµÄÀùÀù¯g·F²ÓM¯S©Ê¬ÛÃö¬ã¨s( )
|
2023/01/01 ~ 2023/12/31 |
| 3 |
111 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X NSTC112-2813-C-037-032-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
112¦~«×¤j±M¾Ç¥Í¬ã¨spµe-§õè°(¥Í§Þ3)( )
|
2023/07/01 ~ 2024/02/29 |
| 4 |
109 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST109-2311-B-037-001 ¡X 1 Ó¤H«¬
p22phox«P¶i¤fµÄÀùÀù¯g·F²ÓM¯S©Ê¤Î¨ä¬ÛÃö¤À¤l¾÷Âà±´°Q( )
|
2020/08/01 ~ 2021/07/31 |
| 5 |
108 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST107-2320-B-037-020-MY2 ¡X 1 Ó¤H«¬
p22phox »P¶¶¹`µ²¦X¤ÎM¥~Åé¦bp22phox¥D¾É¤fµÄÅ쪬¤W¥Ö²ÓMÀù¶¶¹`§ÜÃĩʤ§¨¤¦â(2/2)( )
|
2019/08/01 ~ 2020/07/31 |
| 6 |
108 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST109-2813-C-037-020-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
109¦~«×¤j±M¾Ç¥Í¬ã¨spµe-·¨·ç¼w(Âå§Þ3)( )
|
2020/07/01 ~ 2021/02/28 |
| 7 |
107 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST107-2320-B-037-020-MY2 ¡X 1 Ó¤H«¬
p22phox »P¶¶¹`µ²¦X¤ÎM¥~Åé¦bp22phox¥D¾É¤fµÄÅ쪬¤W¥Ö²ÓMÀù¶¶¹`§ÜÃĩʤ§¨¤¦â(1/2)( )
|
2018/08/01 ~ 2020/07/31 |
| 8 |
106 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST106-2320-B-037-027 ¡X 1 Ó¤H«¬
p22phox»¤µo¤fµÄÀù¶¶¹`§ÜÃĩʤÀ¤l¾÷¨î¤Î¨äÁ{§ÉÀ³¥Î( )
|
2017/08/01 ~ 2018/07/31 |
| 9 |
105 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST105-2320-B-037-016 ¡X 1 Ó¤H«¬
¹L«×ªí²{p22phox³y¦¨¤fµÄÀù¶¶¹`§ÜÃĩʤÀ¤l¾÷Âà:±j½Õ»E¤GÁC»Ä¸¢苷®Ö¿}¤ÎÃþÀ£¤OÁû²É½Æ¦XÅ骺¨¤¦â( )
|
2016/08/01 ~ 2017/07/31 |
| 10 |
105 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP105A13 ¡X
¤lpµe5-3¡BÂb·}¦¨Å}¤À¤l¾÷¨î¤Î¤Æ¾Ç¹w¨¾(2)( )
|
2016/11/01 ~ 2017/10/31 |
| 11 |
105 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST106-2813-C-037-020-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
106¦~«×¤j±M¾Ç¥Í¬ã¨spµe-¥]à±¥È(¥Í§Þ3)( )
|
2017/07/01 ~ 2018/02/28 |
| 12 |
104 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST104-2320-B-037-021 ¡X 1 Ó¤H«¬
p22phox°Ñ»P¤fµÄÀù¶¶¹`§ÜÃĩʤ§¬ÛÃö¾÷Âà¬ã¨s( )
|
2015/08/01 ~ 2016/07/31 |
| 13 |
104 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP104A15 ¡X
¤lpµe6-3¡BÂb·}¦¨Å}¤À¤l¾÷¨î¤Î¤Æ¾Ç¹w¨¾( )
|
2015/10/01 ~ 2016/09/30 |
| 14 |
102 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC102-2320-B-037-016 ¡X 1 Ó¤H«¬
±´°QChloride intracellular channel 3 (CLIC3) ¦b¤fµÄÀù²ÓM¤§¥\¯à¨Ãµû¦ô¦¨¬°¶EÂ_©Î¹w«á¥Íª«¼Ð°O¤§¥i¦æ©Ê( )
|
2013/08/01 ~ 2014/07/31 |
| 15 |
102 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSUKMU102-P021 ¡X 1 Ó¤H«¬
ÃĪ«¦X¦¨¥H¤Î¨ä§ÜÀù®ÄªG¤§µû¦ô(Drug synthesis and the screening of their anti-cancer potentials)
|
2013/01/01 ~ 2013/12/31 |
| 16 |
101 ¡X X °ª©_¦X§@pµe ¡X 102CM-KMU-03 ¡X
p22phoxªí²{¦b¤fµÄÀù¹ïcisplatin§ÜÃĩʤ¤©Ò§êºt¨¤¦â( )
|
2013/05/01 ~ 2014/04/30 |
| 17 |
100 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC98-2311-B-037-002-MY3 ¡X 1 Ó¤H«¬
¬ã¨s¿¸¬rÆP¨üÅé¦bÂb·}²G»¤µo¤fµÄÀù²ÓM²¾Âà»P«I¥Ç§@¥Î¤¤©Ò§êºt¤§¨¤¦â(3/3)( )
|
2011/08/01 ~ 2012/08/31 |
| 18 |
100 ¡X X °ª©_¦X§@pµe ¡X 101CM-KMU-03 ¡X
§Q¥Î·L«¬®ÖÁޮֻİ}¦C¬ã¨scalreticulin¦b¤fµÄÀù©Ò§êºt¤§¨¤¦â( )
|
2012/05/01 ~ 2013/04/30 |
| 19 |
099 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC98-2311-B-037-002-MY3 ¡X 1 Ó¤H«¬
¬ã¨s¿¸¬rÆP¨üÅé¦bÂb·}²G»¤µo¤fµÄÀù²ÓM²¾Âà»P«I¥Ç§@¥Î¤¤©Ò§êºt¤§¨¤¦â(2/3)( )
|
2010/08/01 ~ 2012/08/31 |
| 20 |
099 ¡X X °ª©_¦X§@pµe ¡X 100CM-KMU-05 ¡X
¥»¤g©Ê¤fµÄÀù²ÓM®è¤§«Ø¥ß»P¨ä¯S©Ê¤§¤ÀªR( )
|
2011/05/01 ~ 2012/04/30 |
| 21 |
098 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC98-2311-B-037-002-MY3 ¡X 1 Ó¤H«¬
¬ã¨s¿¸¬rÆP¨üÅé¦bÂb·}²G»¤µo¤fµÄÀù²ÓM²¾Âà»P«I¥Ç§@¥Î¤¤©Ò§êºt¤§¨¤¦â(1/3)( )
|
2009/08/01 ~ 2012/08/31 |
| 22 |
098 ¡X X °ª©_¦X§@pµe ¡X 99CM-KMU-04 ¡X
±´°QRho-GDI£\¦b¤fµÄÀù²ÓM©Ò§êºt¤§¨¤¦â( )
|
2010/05/01 ~ 2011/04/30 |
| 23 |
097 ¡X X °ª©_¦X§@pµe ¡X 98CM-KMU-02 ¡X
±´°Q¿¸¬rÆP¨üÅé¦bÂb·}²G»¤µo¤fµÄÀù²ÓM°T®§¶Ç»¼¤¤©Ò§êºt¤§¨¤¦â( )
|
2009/05/01 ~ 2010/04/30 |
| 24 |
096 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC95-2311-B-037-004-MY2 ¡X 1 Ó¤H«¬
Src¬ÛÃö¿E酶°Ñ»PÂb·}²G©Ò»¤µo¤fµÄÀùÂಾ²{¶H¤§±´°Q(2/2)( )
|
2007/08/01 ~ 2008/07/31 |
| 25 |
095 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC95-2311-B-037-004-MY2 ¡X 1 Ó¤H«¬
SRC ¬ÛÃö¿E–¡°Ñ»PÂb·}²G©Ò»¤µo¤fµÄÀùÂಾ²{¶H¤§±´°Q(1/2)( )
|
2006/08/01 ~ 2008/07/31 |
| 26 |
094 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC94-2320-B-037-047- ¡X 1 Ó¤H«¬
±´°QMAP2¦b¤fµÄÀùÂಾ§@¥Î¤W¥i¯à§êºt¤§¨¤¦â( )
|
2005/08/01 ~ 2006/07/31 |
| 27 |
093 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC 94-2320-B-037-013- ¡X 1 Ó¤H«¬
±´°QMICROTUBULE-ASSOCIATED PROTEIN 2 (MAP2)¦bÂb·}»¤µo¤fµÄÅ쪬²ÓMÀù¤À¤l¾÷Âà¤W©Ò§êºt¤§¨¤¦â( )
|
2005/01/01 ~ 2005/07/31 |
| 28 |
093 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X NSC94-2815-C-037-008 ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
( )
|
2005/07/01 ~ 2006/02/28 |
| 29 |
093 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X NSC94-2815-C-037-009-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
( )
|
2005/07/01 ~ 2006/02/28 |